Acne Market

DelveInsight’s “Acne Market Insights, Epidemiology, and Market Forecast – 2032” report delivers an in-depth understanding of the acne, historical and forecasted epidemiology as well as the acne market trends in the United States.

 

The acne market report provides current treatment practices, emerging drugs, acne market share of individual therapies, and current and forecasted acne market size from 2019 to 2032 in the US. The report also covers current acne treatment practices/algorithms and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.

 

Geography Covered

• The United States

 

Study period: 2019–2032

Acne Treatment Understanding

DelveInsight’s acne market report gives a thorough understanding of acne by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis, and treatment.

Acne is a skin condition that occurs when the hair follicles become plugged with oil and dead skin cells. It causes whiteheads, blackheads, or pimples. Acne is most common among teenagers, though it affects people of all ages. Effective acne treatments are available, but acne can be persistent. The pimples and bumps heal slowly, and when one begins to go away, others seem to crop up. Acne is a common chronic disorder affecting the hair follicle and sebaceous gland, in which there is expansion and blockage of the follicle and inflammation. There are several variants like Acne vulgaris.

The main reason teenagers get acne is that their bodies make more androgen hormones during puberty. Once their hormone levels have settled down – typically by their early twenties – acne usually goes away on its own. But not all teenagers have acne. For this reason, it is believed that other things play a role too, such as genetic factors and the immune system. Thus, risk factors for acne include age, hormonal changes, family history, greasy or oily substances, and friction or pressure on the skin.

 

Acne diagnosis

The diagnosis of acne is based on the history and physical examination. Lesions most commonly develop in areas with the greatest concentration of sebaceous glands, which include the face, neck, chest, upper arms, and back.

 

Acne treatment

Acne medications work by reducing oil production and swelling or by treating bacterial infections. With most prescription acne drugs. It can take many months or years for acne to clear up completely. The most common topical prescription medications for acne are retinoids and retinoid-like drugs, antibiotics, azelaic acid and salicylic acid, and dapsone. Oral medications involve antibiotics, combined oral contraceptives, anti-androgen agents, and isotretinoin.

Some therapies other than pharmacological therapy are also used like light therapy, chemical peel, drainage, and extraction.

Acne Epidemiology

The acne epidemiology section provides insights into the historical and current acne patient pool and forecasted trends for the United States. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the acne report also provides the diagnosed patient pool, their trends, and assumptions undertaken.

 

Key findings

According to the American Academy of Dermatology, acne is the most common skin condition in the United States, affecting up to 50 million Americans annually. Approximately 85% of people between the ages of 12 and 24 experience at least minor acne. Acne occurring in adults is increasing, affecting up to 15% of women.

The acne epidemiology covered in the report provides historical as well as forecasted acne epidemiology [segmented as Total Prevalent Cases of Acne, Gender-specific Prevalent Cases of Acne, Age-specific Prevalent Cases of Acne, Severity-specific Diagnosed Cases of Acne, and Diagnosed and Treatable Cases of Acne] in the United States.

 

Country-wise Acne Epidemiology

The epidemiology segment also provides the acne epidemiology data and findings across the United States.

 

Acne Drug Chapters

The drug chapter segment of the acne report encloses a detailed analysis of acne-marketed drugs and late-stage (Phase III and Phase II) acne pipeline drugs. It also helps understand the acne clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug, and the latest news and press releases.

 

Emerging acne drugs

The report details the emerging acne therapies under the late and mid-stage of development for acne treatment.

 

BTX1503

Botanix Pharmaceuticals is developing BTX1503, a transdermal gel formulation for the treatment of moderate to severe acne. The Phase II trial of the drug has been completed. Synthetic CBD has been shown in scientific studies to normalise excessive lipid synthesis of human sebocytes, suppress cell proliferation, and provide an anti-inflammatory effect potentially reduce bacterial infection. In turn, this could help to reduce the occurrence or severity of serious acne. Phase III trial design is being finalized as per the latest updates by the company yet no recent updates suggest initiation of the trial to date.

 

Note: Detailed emerging therapies assessment will be provided in the full report of acne.

Acne Market Outlook

The acne market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Acne market trends by analyzing the impact of current therapies on the market, unmet needs, and demand for better technology.

This segment gives a thorough detail of the acne market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need for the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

Key players, such as Botanix Pharmaceuticals, Novartis Pharmaceuticals, Bausch Health Americas Inc., and others are developing therapies for the treatment of Acne.

According to DelveInsight, the acne market in the US is expected to witness a major change in the study period 2019–2032.

 

Key findings

This section includes a glimpse of the acne market in the US.

 

The United States: Acne Market Outlook

This section provides the total acne market size and market size by therapies in the United States.

 

Acne Drug Uptake

This section focuses on the rate of uptake of the potential drugs recently launched in the acne market or expected to get launched in the market during the study period 2019–2032. The analysis covers acne market uptake by drugs, patient uptake by therapies, and sales of each drug. 

This will help in understanding the acne drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on market share and size, which again will be useful in investigating factors important in the market uptake and in making financial and regulatory decisions.

 

Acne Pipeline Development Activities

The report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses acne’s key players involved in developing targeted therapeutics.

 

Acne market clinical trial development activities

The report covers detailed information on collaborations, acquisitions, and mergers, licensing patent details, and other information for acne emerging therapies.

 

Acne Reimbursement Scenario

Approaching reimbursement proactively can have a positive impact both during the late stages of product development and well after product launch. In a report, we consider reimbursement to identify economically attractive indications and market opportunities. When working with finite resources, the ability to select the markets with the fewest reimbursement barriers can be a critical business and price strategy.

 

KOL Views

To keep up with current epidemiology and market trends, we take KOLs and SMEs' opinions working in the acne domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies and treatment patterns along with

acne market trends. This will support the clients in potential upcoming novel treatments by identifying the overall scenario of the market and the unmet needs.

 

Competitive Intelligence Analysis

We perform competitive and market intelligence analysis of the acne market by using various competitive intelligence tools that include – SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies, etc. The inclusion of the analysis entirely depends upon the data availability.

 

Scope of the Acne Market Report

• Descriptive overview of acne, disease overview, patient journeys, treatment algorithms, diagnosis, and currently available therapies.
• Comprehensive insight into the acne epidemiology and forecasts in the US.
• An all-inclusive account of both the current and emerging therapies for acne, along with the assessment of new therapies, is expected to have an impact on the current treatment landscape.
• Exhaustive analysis of the acne market; historical and forecasted covering drug outreach in the US.
• Trends shaping and driving the global acne market.

 

Acne Market Report Highlights

• In the coming years, the acne market is set to change due to the increase in the prevalence of acne, along with the expected launch of emerging therapies; which would expand the size of the market to enable drug manufacturers to penetrate more into the market.
• The companies and academics are working to assess challenges and seek opportunities that could influence acne R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition.
• Major players are involved in developing acne therapies. The launch of emerging therapies will significantly impact the acne market.
• Our in-depth analysis of the acne pipeline assets across different stages of development (Phase III and Phase II), emerging trends, and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

 

Acne Report Insights

• Acne Patient population
• Acne Therapeutic approaches
• Acne pipeline analysis
• Acne market size and trends
• Acne market opportunities
• Impact of upcoming therapies

 

Acne Report Key Strengths

• 10 years forecast
• The United States coverage
• Acne epidemiology segmentation
• Key cross competition
• KOL views
• Acne drugs uptake

 

Acne Report Assessment

• Current Acne treatment practices
• Acne Unmet needs
• Acne pipeline product profiles
• Acne market attractiveness
• Acne Market Drivers
• Acne Market Barriers

 

Key Questions Answered In The Acne Market Report

 

Acne market insights:

• What would be the acne market growth till 2032, and what will be the resultant market size in 2032?
• What was the acne drug class share (in percentage) distribution in 2019, and how would it look in 2032?
• What would be the acne total market size and market size by therapies in the US during the forecast period (2019–2032)?
• What are the key findings of the market across the US, and which country will have the largest acne market size during the forecast period (2019–2032)
• How would the unmet needs affect the acne market dynamics and subsequent analysis of the associated trends?

 

Acne Epidemiology Insights:

• What are the disease risk, burden, and regional/ethnic differences of acne?
• What is the historical and forecasted acne patient pool in the US, and where can one observe the highest patient population and growth opportunities?
• What are the key factors driving the epidemiology trends in the US?

 

Current Treatment Scenario, Marketed Drugs, and Emerging Therapies

• What are the current treatment guidelines and treatment options, in addition to approved therapies for Acne in the US?
• What are the key collaborations (Industry–Industry, Industry-Academia), mergers and acquisitions, and licensing activities related to acne therapies?
• What are the recent novel therapies, targets, mechanisms of action, and technologies being developed to overcome the limitation of existing therapies?
• What are the clinical studies going on for acne and its status, along with the challenges faced?

 

Reasons to Buy Acne Market Report

• The report will help in developing business strategies by understanding trends shaping and driving the acne market
• Organize sales and marketing efforts by identifying the best opportunities for acne in the US.
• Identification of strong upcoming players in the market that will help devise strategies that will help in getting ahead of competitors.